ArticleBritish journal of cancer2018

Lessons from the SWITCH trial: changing glucocorticoids in the management of metastatic castration-resistant prostate cancer (mCRPC).

Min Yuen Teo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.